Literature DB >> 33786512

Peripartum Cardiomyopathy: Management Strategies for Pregnancy Termination.

Ashley M Darlington1, Jonah D Fleisher2, Joan E Briller3.   

Abstract

Some women have underlying cardiovascular disease that leads to increased morbidity and mortality with pregnancy. These women may choose to terminate a pregnancy rather than face this increased risk. The optimal approach for pregnancy termination in women with cardiomyopathy is not well defined. We present two women with peripartum cardiomyopathy, both modified World Health Organization (mWHO) class IV and with elevated Cardiac Disease in Pregnancy (CARPREG II) pregnancy risk stratification scores who are at the highest risk for pregnancy continuation. Both underwent induced abortion, although the procedure was performed in very different settings. These cases illustrate factors that influence the mode and setting of pregnancy termination performance. © Ashley M. Darlington et al., 2020; Published by Mary Ann Liebert, Inc.

Entities:  

Keywords:  case reports; perioperative management; peripartum cardiomyopathy; pregnancy termination

Year:  2020        PMID: 33786512      PMCID: PMC7784760          DOI: 10.1089/whr.2020.0078

Source DB:  PubMed          Journal:  Womens Health Rep (New Rochelle)        ISSN: 2688-4844


  10 in total

1.  Prospective multicenter study of pregnancy outcomes in women with heart disease.

Authors:  S C Siu; M Sermer; J M Colman; A N Alvarez; L A Mercier; B C Morton; C M Kells; M L Bergin; M C Kiess; F Marcotte; D A Taylor; E P Gordon; J C Spears; J W Tam; K S Amankwah; J F Smallhorn; D Farine; S Sorensen
Journal:  Circulation       Date:  2001-07-31       Impact factor: 29.690

2.  Medical Compared With Surgical Abortion for Effective Pregnancy Termination in the First Trimester.

Authors:  Luu Doan Ireland; Mary Gatter; Angela Y Chen
Journal:  Obstet Gynecol       Date:  2015-07       Impact factor: 7.661

Review 3.  Risks of contraception and pregnancy in heart disease.

Authors:  Sara Thorne; Anne MacGregor; Catherine Nelson-Piercy
Journal:  Heart       Date:  2006-10       Impact factor: 5.994

4.  Pregnancy Outcomes in Women With Heart Disease: The CARPREG II Study.

Authors:  Candice K Silversides; Jasmine Grewal; Jennifer Mason; Mathew Sermer; Marla Kiess; Valerie Rychel; Rachel M Wald; Jack M Colman; Samuel C Siu
Journal:  J Am Coll Cardiol       Date:  2018-05-29       Impact factor: 24.094

5.  Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Paul Muntner; Alvaro Alonso; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Sandeep R Das; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Lori Chaffin Jordan; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Martin O'Flaherty; Ambarish Pandey; Amanda M Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Connie W Tsao; Mintu P Turakhia; Lisa B VanWagner; John T Wilkins; Sally S Wong; Salim S Virani
Journal:  Circulation       Date:  2019-03-05       Impact factor: 29.690

6.  2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.

Authors:  Lee A Fleisher; Kirsten E Fleischmann; Andrew D Auerbach; Susan A Barnason; Joshua A Beckman; Biykem Bozkurt; Victor G Davila-Roman; Marie D Gerhard-Herman; Thomas A Holly; Garvan C Kane; Joseph E Marine; M Timothy Nelson; Crystal C Spencer; Annemarie Thompson; Henry H Ting; Barry F Uretsky; Duminda N Wijeysundera
Journal:  J Am Coll Cardiol       Date:  2014-08-01       Impact factor: 24.094

7.  Risk and predictors for pregnancy-related complications in women with heart disease.

Authors:  S C Siu; M Sermer; D A Harrison; E Grigoriadis; G Liu; S Sorensen; J F Smallhorn; D Farine; K S Amankwah; J C Spears; J M Colman
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

8.  Cardiovascular effects of intravaginal misoprostol in the mid trimester of pregnancy.

Authors:  P S Ramsey; B B Hogg; K G Savage; D D Winkler; J Owen
Journal:  Am J Obstet Gynecol       Date:  2000-11       Impact factor: 8.661

Review 9.  Risk of subsequent pregnancy in women with a history of peripartum cardiomyopathy.

Authors:  Uri Elkayam
Journal:  J Am Coll Cardiol       Date:  2014-10-14       Impact factor: 24.094

10.  2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.

Authors:  Vera Regitz-Zagrosek; Jolien W Roos-Hesselink; Johann Bauersachs; Carina Blomström-Lundqvist; Renata Cífková; Michele De Bonis; Bernard Iung; Mark Richard Johnson; Ulrich Kintscher; Peter Kranke; Irene Marthe Lang; Joao Morais; Petronella G Pieper; Patrizia Presbitero; Susanna Price; Giuseppe M C Rosano; Ute Seeland; Tommaso Simoncini; Lorna Swan; Carole A Warnes
Journal:  Eur Heart J       Date:  2018-09-07       Impact factor: 29.983

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.